Texas Tech University chemist Dimitri Pappas has received a $520,000 grant to find better methods of studying apoptosis, or programmed cell death. His research could lead to more useful pharmaceutical products for heart disease and cancer. The assistant professor of Chemistry and Biochemistry receives the three-year grant from the National Institutes of Health. Currently, ways to measure apoptosis are time-consuming and limit scientists' understanding of how it might be manipulated, he said. Pappas will use the grant to discover new methods to rapidly measure the rate of death in a number of cells. The work should uncover new targets for pharmaceutical intervention.
Cell death award